AG˹ٷ

STOCK TITAN

[Form 4] The Vita Coco Company, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Corey Baker, Chief Financial Officer of Vita Coco Company, Inc. (COCO), reported two sales of common stock under a Rule 10b5-1 plan. The filings show a sale of 1,000 shares on 09/05/2025 at $38.00 and a sale of 1,000 shares on 09/08/2025 at $38.51, reducing his beneficially owned common stock to 41,754 shares. The report also lists outstanding non-qualified stock options exercisable into common stock: 14,205 shares at a $16.91 strike, 13,481 at $24.35, 8,746 at $26.18, 11,547 at $27.59 and 13,218 at $33.36, each held directly. Several option grants have scheduled vesting dates and installment vesting schedules as described by the reporting person.

Corey Baker, Chief Financial Officer di Vita Coco Company, Inc. (COCO), ha comunicato due vendite di azioni ordinarie effettuate nell'ambito di un piano Rule 10b5-1. I documenti riportano la vendita di 1.000 azioni il 05/09/2025 a 38,00$ e di 1.000 azioni l'08/09/2025 a 38,51$, riducendo la sua partecipazione in azioni ordinarie a 41.754 azioni. Il rapporto elenca inoltre opzioni azionarie non qualificate in essere esercitabili in azioni ordinarie: 14.205 azioni a un prezzo di esercizio di 16,91$, 13.481 a 24,35$, 8.746 a 26,18$, 11.547 a 27,59$ e 13.218 a 33,36$, tutte detenute direttamente. Diversi grant di opzioni prevedono date di maturazione e piani di vesting in tranche come specificato dal dichiarante.

Corey Baker, Director Financiero de Vita Coco Company, Inc. (COCO), informó dos ventas de acciones comunes bajo un plan Rule 10b5-1. Las presentaciones muestran la venta de 1.000 acciones el 05/09/2025 a 38,00$ y de 1.000 acciones el 08/09/2025 a 38,51$, reduciendo su participación en acciones comunes a 41.754 acciones. El informe también enumera opciones sobre acciones no calificadas pendientes ejercitables en acciones comunes: 14.205 acciones con un precio de ejercicio de 16,91$, 13.481 a 24,35$, 8.746 a 26,18$, 11.547 a 27,59$ y 13.218 a 33,36$, todas en propiedad directa. Varias concesiones de opciones tienen fechas de adquisición y cronogramas de vesting por cuotas según lo descrito por el informante.

코리 베이�(본사 재무책임�, Vita Coco Company, Inc. (COCO))가 Rule 10b5-1 계획� 따라 보통� � 건을 매도했다� 보고했습니다. 제출서류� 따르� 2025-09-05� 1,000주를 주당 38.00달러�, 2025-09-08� 1,000주를 주당 38.51달러� 매도� 그의 보유 보통주가 41,754�� 감소했습니다. 보고서에� 또한 보통주로 행사 가능한 비적� 스톡옵션� 다음� 같이 기재되어 있습니다: 행사가 16.91달러� 14,205�, 24.35달러� 13,481�, 26.18달러� 8,746�, 27.59달러� 11,547�, 33.36달러� 13,218주로 모두 직접 보유 중입니다. 여러 옵션 부여에� 보고자가 설명� 대� 만기� � 할부� 베스� 일정� 있습니다.

Corey Baker, directeur financier de Vita Coco Company, Inc. (COCO), a déclaré deux ventes d'actions ordinaires dans le cadre d'un plan Rule 10b5-1. Les documents indiquent la vente de 1 000 actions le 05/09/2025 à 38,00$ et de 1 000 actions le 08/09/2025 à 38,51$, réduisant sa détention d'actions ordinaires à 41 754 actions. Le rapport énumère également des options sur actions non qualifiées en instance, exerçables en actions ordinaires : 14 205 actions au prix d'exercice de 16,91$, 13 481 à 24,35$, 8 746 à 26,18$, 11 547 à 27,59$ et 13 218 à 33,36$, toutes détenues directement. Plusieurs attributions d'options comportent des dates d'acquisition et des calendriers de vesting échelonnés, tels que décrits par le déclarant.

Corey Baker, Finanzvorstand von Vita Coco Company, Inc. (COCO), meldete zwei Verkäufe von Stammaktien im Rahmen eines Rule-10b5-1-Plans. Den Unterlagen zufolge wurden am 05.09.2025 1.000 Aktien zu je 38,00$ und am 08.09.2025 1.000 Aktien zu je 38,51$ verkauft, wodurch sein wirtschaftlicher Bestand an Stammaktien auf 41.754 Aktien gesunken ist. Der Bericht listet außerdem noch ausstehende nicht qualifizierte Aktienoptionen, die in Stammaktien ausgeübt werden können: 14.205 Aktien zu einem Ausübungspreis von 16,91$, 13.481 zu 24,35$, 8.746 zu 26,18$, 11.547 zu 27,59$ und 13.218 zu 33,36$, jeweils direkt gehalten. Mehrere Optionszuteilungen sehen Fälligkeitsdaten und Raten- bzw. Staffel-Vesting-Pläne vor, wie vom Berichtenden erläutert.

Positive
  • Transactions executed under a Rule 10b5-1 plan, indicating pre-established trading instructions and compliance with insider trading protocols
  • Detailed option and vesting schedules disclosed, providing transparency about future potential dilution and executive alignment with equity
Negative
  • Reduction in direct common stock holdings from 42,754 to 41,754 shares following the reported sales

Insights

TL;DR: Routine insider sales under a 10b5-1 plan; no new equity issuance or debt changes reported.

The Form 4 discloses two small open-market sales by the CFO executed pursuant to a pre-established Rule 10b5-1 trading plan, which suggests these transactions follow a predetermined schedule rather than opportunistic timing. The filing confirms continued equity exposure via substantial outstanding options across multiple strike prices and staggered vesting schedules. There is no indication in the filing of additional corporate actions or material changes to capital structure.

TL;DR: Disclosure is compliant and shows typical officer liquidity within a structured trading plan.

The report includes required details: transaction dates, amounts, prices, ownership after sale, and explanatory vesting terms for options. Use of a Rule 10b5-1 plan is explicitly noted, which supports an affirmative defense to insider trading claims so long as plan conditions were met. The attestation by an attorney-in-fact is present. No governance irregularities or departures are disclosed.

Corey Baker, Chief Financial Officer di Vita Coco Company, Inc. (COCO), ha comunicato due vendite di azioni ordinarie effettuate nell'ambito di un piano Rule 10b5-1. I documenti riportano la vendita di 1.000 azioni il 05/09/2025 a 38,00$ e di 1.000 azioni l'08/09/2025 a 38,51$, riducendo la sua partecipazione in azioni ordinarie a 41.754 azioni. Il rapporto elenca inoltre opzioni azionarie non qualificate in essere esercitabili in azioni ordinarie: 14.205 azioni a un prezzo di esercizio di 16,91$, 13.481 a 24,35$, 8.746 a 26,18$, 11.547 a 27,59$ e 13.218 a 33,36$, tutte detenute direttamente. Diversi grant di opzioni prevedono date di maturazione e piani di vesting in tranche come specificato dal dichiarante.

Corey Baker, Director Financiero de Vita Coco Company, Inc. (COCO), informó dos ventas de acciones comunes bajo un plan Rule 10b5-1. Las presentaciones muestran la venta de 1.000 acciones el 05/09/2025 a 38,00$ y de 1.000 acciones el 08/09/2025 a 38,51$, reduciendo su participación en acciones comunes a 41.754 acciones. El informe también enumera opciones sobre acciones no calificadas pendientes ejercitables en acciones comunes: 14.205 acciones con un precio de ejercicio de 16,91$, 13.481 a 24,35$, 8.746 a 26,18$, 11.547 a 27,59$ y 13.218 a 33,36$, todas en propiedad directa. Varias concesiones de opciones tienen fechas de adquisición y cronogramas de vesting por cuotas según lo descrito por el informante.

코리 베이�(본사 재무책임�, Vita Coco Company, Inc. (COCO))가 Rule 10b5-1 계획� 따라 보통� � 건을 매도했다� 보고했습니다. 제출서류� 따르� 2025-09-05� 1,000주를 주당 38.00달러�, 2025-09-08� 1,000주를 주당 38.51달러� 매도� 그의 보유 보통주가 41,754�� 감소했습니다. 보고서에� 또한 보통주로 행사 가능한 비적� 스톡옵션� 다음� 같이 기재되어 있습니다: 행사가 16.91달러� 14,205�, 24.35달러� 13,481�, 26.18달러� 8,746�, 27.59달러� 11,547�, 33.36달러� 13,218주로 모두 직접 보유 중입니다. 여러 옵션 부여에� 보고자가 설명� 대� 만기� � 할부� 베스� 일정� 있습니다.

Corey Baker, directeur financier de Vita Coco Company, Inc. (COCO), a déclaré deux ventes d'actions ordinaires dans le cadre d'un plan Rule 10b5-1. Les documents indiquent la vente de 1 000 actions le 05/09/2025 à 38,00$ et de 1 000 actions le 08/09/2025 à 38,51$, réduisant sa détention d'actions ordinaires à 41 754 actions. Le rapport énumère également des options sur actions non qualifiées en instance, exerçables en actions ordinaires : 14 205 actions au prix d'exercice de 16,91$, 13 481 à 24,35$, 8 746 à 26,18$, 11 547 à 27,59$ et 13 218 à 33,36$, toutes détenues directement. Plusieurs attributions d'options comportent des dates d'acquisition et des calendriers de vesting échelonnés, tels que décrits par le déclarant.

Corey Baker, Finanzvorstand von Vita Coco Company, Inc. (COCO), meldete zwei Verkäufe von Stammaktien im Rahmen eines Rule-10b5-1-Plans. Den Unterlagen zufolge wurden am 05.09.2025 1.000 Aktien zu je 38,00$ und am 08.09.2025 1.000 Aktien zu je 38,51$ verkauft, wodurch sein wirtschaftlicher Bestand an Stammaktien auf 41.754 Aktien gesunken ist. Der Bericht listet außerdem noch ausstehende nicht qualifizierte Aktienoptionen, die in Stammaktien ausgeübt werden können: 14.205 Aktien zu einem Ausübungspreis von 16,91$, 13.481 zu 24,35$, 8.746 zu 26,18$, 11.547 zu 27,59$ und 13.218 zu 33,36$, jeweils direkt gehalten. Mehrere Optionszuteilungen sehen Fälligkeitsdaten und Raten- bzw. Staffel-Vesting-Pläne vor, wie vom Berichtenden erläutert.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BAKER COREY

(Last) (First) (Middle)
250 PARK AVE SOUTH
SEVENTH FLOOR

(Street)
NEW YORK NY 10003

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/05/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/05/2025 S(1) 1,000 D $38 42,754 D
Common Stock 09/08/2025 S(1) 1,000 D $38.51 41,754 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (right to buy) $16.91 (2) 03/10/2033 Common Stock 14,205 14,205 D
Non-Qualified Stock Option (right to buy) $24.35 (3) 05/10/2033 Common Stock 13,481 13,481 D
Non-Qualified Stock Option (right to buy) $26.18 (4) 03/04/2034 Common Stock 8,746 8,746 D
Non-Qualified Stock Option (right to buy) $27.59 (3) 08/07/2033 Common Stock 11,547 11,547 D
Non-Qualified Stock Option (right to buy) $33.36 (5) 03/04/2035 Common Stock 13,218 13,218 D
Explanation of Responses:
1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. The stock option vests in four equal annual installments beginning on March 10, 2024.
3. The stock option is vested as to 40% and will vest the remaining 30% on March 10, 2025, 20% on March 10, 2026 and 10% on March 10, 2027.
4. The stock option vests in four equal annual installments beginning on March 4, 2025.
5. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.
By: Alison Klein, Attorney-in-Fact For: Corey Baker 09/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What trades did COCO CFO Corey Baker report on Form 4?

The Form 4 reports sales of 1,000 shares on 09/05/2025 at $38.00 and 1,000 shares on 09/08/2025 at $38.51.

Were the sales by Corey Baker part of a 10b5-1 plan?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan.

How many shares does Corey Baker beneficially own after these transactions?

Following the reported transactions, the filing shows Corey Baker beneficially owns 41,754 shares of common stock.

What stock options does Corey Baker hold according to the Form 4?

The Form 4 lists non-qualified stock options exercisable into 14,205; 13,481; 8,746; 11,547; and 13,218 common shares at strikes of $16.91, $24.35, $26.18, $27.59, and $33.36, respectively.

Are there vesting schedules disclosed for the options?

Yes. The filing discloses various vesting schedules including four-year installment vesting and specific milestone vesting dates for certain grants.
Vita Coco Company, Inc.

NASDAQ:COCO

COCO Rankings

COCO Latest News

COCO Latest SEC Filings

COCO Stock Data

2.18B
50.67M
10.72%
85.49%
9.87%
Beverages - Non-Alcoholic
Beverages
United States
NEW YORK